View Author
patient bladder cancer recurrence bladder cancer mutation study cystoscopy urine tumor analysis progression surveillance grade tumour factor stage tumours carcinoma prognostic fgfr 3 mutations detection sample nmi uc follow-up urothelial prognostic factors result van der kwast urine samples status sensitivity test arm disease fgfr 3 trial table month system microsatellite analysis marker urology value chapter health number diagnosis microsatellite group urothelial cell carcinoma figure pt 1 uc questionnaire outcome department fgfr 3 mutation growth fgfr 3 status series review survival pathology cystoscopie effect presence randomized treatment assay specificity kwast method burden tract control urine test outcome intervention arm urine test non-muscle zwarthoff intervention
10 Most Recent Publications
|
FGFR3, HRAS, KRAS, NRAS AND PIK3CA mutations in bladder cancer and their potential as biomarkers for surveillance and therapy
(Article)
Kompier, L.C. Lurkin, I. Aa, M.N.M. van der Rhijn, B.W.G. van Kwast, Th.H. van der Zwarthoff, E.C. |
2010-11-18
|
|
Pathological stage review is indicated in primary pT1 bladder cancer
(Article)
Rhijn, B.W.G. van Kwast, Th.H. van der Kakiashvili, D.M. Fleshner, N.E. Aa, M.N.M. van der Alkhateeb, S. Bangma, C.H. Jewett, M.A.S. Zlotta, A.R. |
2010-07-01
|
|
Fibroblast growth factor receptor 3 mutation analysis on voided urine for surveillance of patients with low-grade non-muscle - Invasive bladder cancer
(Article)
Zuiverloon, T.C.M. Aa, M.N.M. van der Kwast, Th.H. van der Steyerberg, E.W. Roozenbeek, B. Bangma, C.H. Zwarthoff, E.C. |
2010-06-01
|
|
Cystoscopy Revisited as the Gold Standard for Detecting Bladder Cancer Recurrence: Diagnostic Review Bias in the Randomized, Prospective CEFUB Trial
(Article)
Aa, M.N.M. van der Steyerberg, E.W. Bangma, C.H. Rhijn, B.W.G. van Zwarthoff, E.C. Kwast, Th.H. van der |
2010-01-01
|
|
Clinical and pathological prognostic factors for recurrence, progression and mortality in non-muscle invasive bladder cancer: A meta-analysis
(Article)
Aa, M.N.M. van der Dönmez, M. Eijkemans, M.J.C. Kwast, Th.H. van der Zwarthoff, E.C. Steyerberg, E.W. |
2009-11-01
|
|
Non-muscle-invasive bladder cancer surveillance for which cystoscopy is partly replaced by microsatellite analysis of urine: a cost-effective alternative?
(Article)
Bekker-Grob, E.W. de Aa, M.N.M. van der Zwarthoff, E.C. Eijkemans, M.J.C. Rhijn, B.W. van Kwast, Th.H. van der Steyerberg, E.W. |
2009-07-31
|
|
Sexual function of patients under surveillance for bladder cancer
(Article)
Aa, M.N.M. van der Bekker, M.D. Kwast, Th.H. van der Essink-Bot, M.L.E. Steyerberg, E.W. Zwarthoff, E.C. Sen, E.F. Elzevier, H.W. |
2009-07-01
|
|
The development of multiple bladder tumour recurrences in relation to the FGFR3 mutation status of the primary tumour
(Article)
Kompier, L.C. Aa, M.N.M. van der Lurkin, I. Vermeij, M. Kirkels, W.J. Bangma, C.H. Kwast, Th.H. van der Zwarthoff, E.C. |
2009-05-01
|
|
Microsatellite Analysis of Voided-Urine Samples for Surveillance of Low-Grade Non-Muscle-Invasive Urothelial Carcinoma: Feasibility and Clinical Utility in a Prospective Multicenter Study (Cost-Effectiveness of Follow-Up of Urinary Bladder Cancer Trial [CEFUB])
(Article)
Aa, M.N.M. van der Zwarthoff, E.C. Steyerberg, E.W. Boogaard, M.W. Nijsen, Y. Keur, K.A. van der Exsel, A.J.A. van Kirkels, W.J. Bangma, C.H. Kwast, Th.H. van der |
2009-03-01
|
|
Surveillance of bladder cancer
(Doctoral Thesis)
Aa, M.N.M. van der |
2009-02-25
|
